Title of article
The spectrum of neuromyelitis optica
Author/Authors
Dean M. Wingerchuk، نويسنده , , Vanda A. Lennon، نويسنده , , Claudia F Lucchinetti، نويسنده , , Sean J Pittock، نويسنده , , Brian G Weinshenker، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2007
Pages
11
From page
805
To page
815
Abstract
Summary
Neuromyelitis optica (also known as Devicʹs disease) is an idiopathic, severe, demyelinating disease of the central nervous system that preferentially affects the optic nerve and spinal cord. Neuromyelitis optica has a worldwide distribution, poor prognosis, and has long been thought of as a variant of multiple sclerosis; however, clinical, laboratory, immunological, and pathological characteristics that distinguish it from multiple sclerosis are now recognised. The presence of a highly specific serum autoantibody marker (NMO-IgG) further differentiates neuromyelitis optica from multiple sclerosis and has helped to define a neuromyelitis optica spectrum of disorders. NMO-IgG reacts with the water channel aquaporin 4. Data suggest that autoantibodies to aquaporin 4 derived from peripheral B cells cause the activation of complement, inflammatory demyelination, and necrosis that is seen in neuromyelitis optica. The knowledge gained from further assessment of the exact role of NMO-IgG in the pathogenesis of neuromyelitis optica will provide a foundation for rational therapeutic trials for this rapidly disabling disease.
Journal title
Lancet Neurology
Serial Year
2007
Journal title
Lancet Neurology
Record number
802019
Link To Document